01 1Aurobindo Pharma Limited
02 1Azico Biophore India Private Limited
03 1HIKAL LIMITED
04 1Honour Lab Limited
05 2MSN Laboratories Private Limited
06 1Upjohn Manufacturing Ireland Unlimited Company
01 1ERTUGLIFLOZIN
02 3Ertugliflozin
03 1Ertugliflozin L-Pyroglutamic Acid
04 1Ertugliflozin L-Pyroglutamic acid
05 1Ertugliflozin Pidolate
01 6India
02 1U.S.A
ERTUGLIFLOZIN L-PYROGLUTAMIC ACID
NDC Package Code : 59651-598
Start Marketing Date : 2023-12-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69575-4057
Start Marketing Date : 2021-12-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66651-926
Start Marketing Date : 2019-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0068
Start Marketing Date : 2017-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0110
Start Marketing Date : 2022-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0107
Start Marketing Date : 2021-08-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61947-0849
Start Marketing Date : 2017-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ertugliflozin L-Pyroglutamic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ertugliflozin L-Pyroglutamic Acid, including repackagers and relabelers. The FDA regulates Ertugliflozin L-Pyroglutamic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ertugliflozin L-Pyroglutamic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ertugliflozin L-Pyroglutamic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ertugliflozin L-Pyroglutamic Acid supplier is an individual or a company that provides Ertugliflozin L-Pyroglutamic Acid active pharmaceutical ingredient (API) or Ertugliflozin L-Pyroglutamic Acid finished formulations upon request. The Ertugliflozin L-Pyroglutamic Acid suppliers may include Ertugliflozin L-Pyroglutamic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Ertugliflozin L-Pyroglutamic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ertugliflozin L-Pyroglutamic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ertugliflozin L-Pyroglutamic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ertugliflozin L-Pyroglutamic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ertugliflozin L-Pyroglutamic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ertugliflozin L-Pyroglutamic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ertugliflozin L-Pyroglutamic Acid suppliers with NDC on PharmaCompass.
We have 6 companies offering Ertugliflozin L-Pyroglutamic Acid
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
